SPSairam Parthasarathy

Sairam Parthasarathy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sairam Parthasarathy has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Longitudinal differences in sleep duration in Hispanic and Caucasian children

    by Daniel Combs, James L. Goodwin, Stuart F. Quan, Wayne J. Morgan, Sairam Parthasarathy


  • A Meta-analysis of Sleep-promoting Interventions During Critical Illness

    by Chithra Poongkunran, Santosh G. John, Arun S. Kannan, Safal Shetty, Christian Bime, Sairam Parthasarathy


  • Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease

    by Steven Coughlin, Wei E Liang, Sairam Parthasarathy

    Healthcare systems are attempting to reduce hospital readmissions due to chronic obstructive pulmonary disease (COPD). A retrospective study of a quality improvement (QI) program performed at a single center whose multifaceted intervention included nocturnal administration of advanced positive airway pressure (PAP) modality (or noninvasive positive pressure ventilation [NIPPV]) called averaged volume assured pressure support (AVAPS-AE) initiation by a respiratory therapist (RT), medication reconciliation by a pharmacist, adequate provision of oxygen, and ongoing RT-led care. In this QI program, consecutive patients who had been hospitalized twice in a single year with an acute COPD exacerbation underwent such interventions after they met specific selection criteria. Three-hundred ninety-seven consecutive patients were eligible for the program because they had two or more hospitalizations in the previous year. The proportion of patients who were readmitted on two or more occasions decreased from 100% (397 of 397) in the year prior to initiation of intervention to 2.2% (9 of 397) in the following year (χ(2) = 758, p < 0.0001). Seventy patients died over the one year following initiation of the multifaceted intervention. A composite outcome of rehospitalization and death was associated with inhaled steroids (adjusted odds ratio [adjOR] of 2.13; 95% confidence interval [CI] 1.09, 4.17; p = 0.02), whereas inhaled antimuscarinics tended to be associated with less risk for rehospitalization or death (adjOR 0.56; 95% CI 0.34, 1.03; p = 0.06). In a retrospective cohort study of a QI initiative undertaken at a single center, we have observed that a multifaceted intervention that involved initiation of nocturnal advanced PAP (NIPPV) modality, RT-led respiratory care, medication reconciliation, appropriate oxygen therapy initiation, and patient education led to significant reduction in rehospitalization.


  • Persistent Insomnia is Associated with Mortality Risk

    by Sairam Parthasarathy, Monica M. Vasquez, Marilyn Halonen, Richard Bootzin, Stuart F. Quan, Fernando D. Martinez, Stefano Guerra


  • Obesity hypoventilation syndrome

    by Safal Shetty, Sairam Parthasarathy

    Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive, and sleep-disordered breathing. Early diagnosis and treatment is important because delay in treatment is associated with significant mortality and morbidity. Available treatment options include noninvasive positive airway pressure (PAP) therapies and weight loss. There is limited long-term data regarding the effectiveness of such therapies. This review outlines the current concepts of clinical presentation and diagnostic and management strategies to help identify and treat patients with obesity hypoventilation syndromes.


  • Cerebrovascular Reactivity in Young Subjects with Sleep Apnea

    by John Buterbaugh, Charles Wynstra, Natalie Provencio, Daniel Combs, Michael Gilbert, Sairam Parthasarathy

    S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.


  • Narcolepsy: Let the Patient's Voice Awaken Us!

    by Julie Flygare, Sairam Parthasarathy


  • A Pilot Study of CPAP Adherence Promotion by Peer Buddies with Sleep Apnea

    by Sairam Parthasarathy, Christopher Wendel, Patricia L. Haynes, Charles Atwood, Samuel Kuna

    To evaluate patient ratings of the acceptability of a peer buddy system (PBS). To promote continuous positive airway pressure (CPAP) therapy adherence in patients with obstructive sleep apnea (OSA). To obtain preliminary data on the effectiveness of PBS on sleep-specific health-related quality of life and CPAP adherence. Prospective, randomized, and controlled study. Academic Center. Thirty-nine patients with OSA and 13 patients with OSA who were experienced CPAP users. Recently diagnosed patients with OSA were randomly assigned to either the PBS to promote CPAP adherence (intervention group) or usual care (control group). Patient satisfaction, Functional Outcomes of Sleep Questionnaire (FOSQ), CPAP adherence, vigilance, self-efficacy, and patient activation were measured. Ninety-one percent of the subjects rated the PBS as very satisfactory (68%) or satisfactory (23%). During the 90 days of therapy, weekly CPAP adherence was greater in the intervention than the usual care group (MANOVA; F = 2.29; p = 0.04). Patient satisfaction was positively correlated with CPAP adherence (R(2) = 0.14; p = 0.02). We did not find any group differences for FOSQ, vigilance, self-efficacy, or patient activation in this pilot study. Our pilot study suggests that the PBS intervention is feasible and received high patient satisfaction ratings. CPAP adherence may be improved by peer-driven intervention, but a larger, adequately powered study is needed. ClinicalTrials.gov identifier: NCT01164683. A commentary on this article appears in this issue on page 551. Parthasarathy S; Wendel C; Haynes PL; Atwood C; Kuna S. A pilot study of CPAP adherence promotion by peer buddies with sleep apnea. J Clin Sleep Med 2013;9(6):543-550.


  • Sleep, Circadian Rhythms, and Critical Illness

    by Sairam Parthasarathy, Randall Friese

    S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.


  • Refill Rates of Accessories for Positive Airway Pressure Therapy as a Surrogate Measure of Long-Term Adherence

    by Nimesh Patel, Afshin Sam, Alexandra Valentin, Stuart F Quan, Sairam Parthasarathy

    To identify and validate a surrogate measure of long-term adherence to positive airway pressure (PAP) therapy in patients with obstructive sleep apnea (OSA). Retrospective cohort study. Academic center. 220 consecutive patients with OSA. N/A. In patients with OSA who were receiving PAP therapy (for > 1 year), PAP adherence measured by device-download and defined by Medicare criteria was compared to refill rates for mask and other PAP therapy accessories. First, receiver operating characteristic (ROC) curves were constructed to identify a threshold value of refills per year that discriminated best between PAP adherent and non-adherent patients (derivation set; n = 100). Then the predictive accuracy of the threshold value of refills per year was tested in an additional 120 consecutive patients (validation set). From the derivation set, ROC curve with good discriminant characteristics (ROC 0.83; 95% confidence intervals [CI], 0.75, 0.91, p < 0.0001) was used to identify a threshold value of refills (0.7 refills/year) for distinguishing PAP adherent and non-adherent patients. Subsequently, when the threshold was applied to the validation set, the likelihood ratio for a positive test (weighted for prevalence) predicting adherence to PAP therapy was 7.3 (95%CI, 3.8, 14), and likelihood ratio for a negative test was 0.6 (95%CI; 0.4, 0.8). Refill rate of PAP accessories exhibited good test characteristics for predicting long-term PAP adherence. Such a surrogate measure based upon insurance claims data can be a powerful epidemiological tool in bioinformatics-aided comparative-effectiveness research and to monitor clinical performance of health systems.